We report the neuroprotective effects of bosutinib on the survival of UBQLN2 mutant ALS iMNs, highlighting its potential mitigating neuronal death in UBQLN2-related ALS. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.